Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 8;3(2):dlab038.
doi: 10.1093/jacamr/dlab038. eCollection 2021 Jun.

The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective

Shamshul Ansari  1 , John P Hays  2 , Andrew Kemp  3 , Raymond Okechukwu  4 , Jayaseelan Murugaiyan  5 , Mutshiene Deogratias Ekwanzala  6   7 , Maria Josefina Ruiz Alvarez  8 , Maneesh Paul-Satyaseela  9 , Chidozie Declan Iwu  10 , Clara Balleste-Delpierre  11 , Ed Septimus  12 , Lawrence Mugisha  13 , Joseph Fadare  14 , Susmita Chaudhuri  15 , Vindana Chibabhai  16 , J M Rohini W W Wadanamby  17 , Ziad Daoud  18 , Yonghong Xiao  19 , Thulasiraman Parkunan  20 , Yara Khalaf  21 , Nkuchia M M'Ikanatha  22 , Maarten B M van Dongen  23 ; Global AMR Insights Ambassador Network
Affiliations
Review

The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective

Shamshul Ansari et al. JAC Antimicrob Resist. .

Abstract

The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Timeline of severe human coronavirus strains.
Figure 2.
Figure 2.
The most relevant predictors playing a role in the global development of AMR in the face of the worldwide COVID-19 pandemic.
Figure 3.
Figure 3.
The key points to AMR control strategies in the age of COVID-19.
See this image and copyright information in PMC

References

    1. Zhu N, Zhang D, Wang W et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727–33. - PMC - PubMed
    1. Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395: 565–74. - PMC - PubMed
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536–44. - PMC - PubMed
    1. Sola I, Almazan F, Zuniga S et al. Continuous and discontinuous RNA synthesis in coronaviruses. Annu Rev Virol 2015; 2: 265–88. - PMC - PubMed
    1. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018; 23: 130–7. - PMC - PubMed